Wnt-5a Activators
Common Wnt-5a Activators include, but are not limited to Lithium Chloride CAS 7447-41-8, SB-216763 CAS 280744-09-4, GSK-3 Inhibitor IX CAS 667463-62-9, GSK-3 Inhibitor XVI CAS 252917-06-9 and Valproic Acid CAS 99-66-1.
Wnt-5a activators are compounds that stimulate the activity or expression of Wnt-5a, a member of the Wnt family of secreted lipid-modified glycoproteins. The Wnt signaling pathway is evolutionarily conserved and plays crucial roles in embryogenesis, cell fate determination, and tissue homeostasis. While the Wnt family comprises numerous members, Wnt-5a is particularly notable for its involvement in the non-canonical or β-catenin-independent Wnt signaling pathways, distinguishing it from other Wnts that primarily activate the canonical β-catenin-dependent pathway.
Wnt-5a, upon binding to specific Frizzled receptors on the cell surface, activates a variety of intracellular signaling cascades, including the planar cell polarity (PCP) pathway and the Wnt/Ca^2+ pathway. These pathways subsequently modulate various cellular processes, such as cell polarity, migration, and calcium homeostasis. Wnt-5a activators, by enhancing the protein's activity or expression, can potentiate these non-canonical Wnt signaling events. Understanding the mechanisms and implications of Wnt-5a activation offers profound insights into the diverse roles this protein plays in cellular dynamics and development. Delving into the realm of Wnt-5a activators underscores its significance in orchestrating a multitude of cellular behaviors, emphasizing the importance of the Wnt signaling pathway in determining cell fate, guiding tissue morphogenesis, and ensuring the maintenance of tissue structures. The nuanced modulation of Wnt-5a activity offers a broader perspective on the intricate web of signaling events that steer cellular and developmental processes, reflecting the elaborate choreography of molecular interactions that shape life's complexity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium is known to inhibit GSK-3β, which can stabilize β-catenin and potentially increase WNT-5A expression. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB216763 is a GSK-3β inhibitor. By inhibiting GSK-3β, it might stabilize β-catenin and influence WNT-5A expression. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
GSK-3 Inhibitor IX is a specific inhibitor of GSK-3, and its inhibition can potentially enhance WNT-5A expression via β-catenin stabilization. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
GSK-3 Inhibitor XVI is a potent GSK-3β inhibitor. By inhibiting GSK-3β, it can potentially increase WNT-5A expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid is a histone deacetylase (HDAC) inhibitor that can influence various gene expressions, possibly including WNT-5A. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As an HDAC inhibitor, trichostatin A might modulate the expression of various genes, potentially influencing WNT-5A expression. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine, a CDK inhibitor, might have effects on the cell cycle, which could indirectly influence WNT-5A expression. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 can activate the Wnt/β-catenin pathway, which might lead to increased WNT-5A expression. | ||||||
Pyrvinium Pamoate | 3546-41-6 | sc-476920A sc-476920 | 250 mg 500 mg | $228.00 $422.00 | ||
Pyrvinium pamoate can activate the Wnt/β-catenin pathway, potentially leading to increased WNT-5A expression. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
XAV939 stabilizes axin by inhibiting tankyrase, which in turn promotes β-catenin degradation, potentially influencing WNT-5A expression. | ||||||